Impact of cytochrome P450 2D6 polymorphisms on decision-making and clinical outcomes in adjuvant hormonal therapy for breast cancer

Table 1 Primers for cytochrome P450 2D6 genotyping

	Position/change	Forward primer (5’→3’)	Reverse primer (5’→3’)
*4	1846G>A	AGA GGC GCT TCT CCG TGT CC	AAA TCC TGC TCT TCC GAG GC
*5	Gene deletion	CTC CAG CCT CCA CCA GTC CAG	CAG GCA TGA GCT AAG GCA CCC AGA C
*6	1707delT	CGC AAC TTG GGC CTG GGC AAG AAG TCG CTG GAC TAG	CTC GGG AGC TCG CCC TGC AGA GAC TC
*9	2613AGA>del	GGT CAG TGG TAA GGA CAG GCA GGC CC	CAC CCT TGC CCC CCA CCG TGG CAG CCA CTC TAA GCT
*10	100C>T	GAT GCA CCG GCG CCA ACG CTG GGC TGC ACG GTA C	CAA ACC TGC TTC CCC TTC TCA GCC
*41	2988G>A	CGT GAG CCC ATC TGG GAA A	CTG ACA CTC CTT CTT GCC TCC TA